Registry Study of Patients Undergoing Endoscopic Retrograde Cholangiopancreatography ERCP at Methodist Dallas Medical Center

What this Trial Is About

This research aims to collect and store detailed information about patients who undergo Endoscopic Retrograde Cholangiopancreatography ERCP procedures at Methodist Dallas Medical Center. The study focuses on factors influencing the risk of pancreatitis following ERCP, a serious complication, and supports quality improvement and research efforts related to gastro-intestinal disorders. Patients included in this registry are those who had ERCP performed at the center between January 1, 2000, and December 31, 2025. The study gathers data permissively for up to 25 years to monitor patient outcomes and procedural details. No specific treatments or interventions are assigned instead, data from past and future ERCP cases are collected for observational purposes. Participants information, including procedural records and outcomes, will be stored and analyzed to understand risks and improve care. The primary measure is the inclusion of patients who underwent ERCP over the 25-year period. The study does not involve additional interventions or treatment changes and will continue data collection until the end date in February 2028.

Endoscopic Retrograde Cholangiopancreatography